BSE filing, BSE: 544805. Summary written from the filing by ALFA Finder's alert engine.
Jivial Industries Ltd: key numbers
- Share price
- ₹76.50
- Market cap
- ₹35.72 Cr
- Revenue (annual)
- ₹17.63 Cr
- Net profit (annual)
- ₹3.75 Cr
- P/E (TTM)
- 9.5×Sector 16.7×
- Promoter holding
- 61.17%
- FII holding
- 9.52%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jivial Industries Ltd
All →Jivial Industries Board Meeting Date
Jivial Industries has scheduled a board meeting for 5 November 2026 to approve H1 unaudited results and appoint an additional independent director. Agenda items are proposed and not yet decided.
Jivial Industries Management Change
Jivial Industries' board accepted CFO Dhara Vekariya's resignation and appointed Mr. Shubham Sagpariya as the new CFO effective 22 Oct 2026. The board also approved a postal ballot to alter IPO objects.
Jivial Industries Other Announcement
Jivial Industries Ltd filed its quarterly shareholding pattern as of September 30, 2026. This disclosure details the distribution of equity shares across various investor categories.
Jivial Industries Annual General Meeting
Jivial Industries Ltd held its 5th Annual General Meeting on 30th September, 2026 via video conferencing. The meeting transacted ordinary business, including adoption of financial statements.
Jivial Industries Annual Report
Jivial Industries Limited has filed its Annual Report for the Financial Year 2025-26, which includes the Notice for its 5th Annual General Meeting.
Jivial Industries Annual General Meeting
Jivial Industries Ltd has announced the closure of its register of members from September 21 to September 30, 2026, for its 5th Annual General Meeting.
Other other announcement announcements
All →Glenmark Pharmaceuticals Other Announcement
Glenmark's partner IGI will present updated Phase 1 clinical data for ISB 2001 (ABBV-2001) in relapsed/refractory multiple myeloma at the 68th ASH Annual Meeting. The presentation is scheduled for December 12, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories' board appointed SVRL & Co. as statutory auditors, subject to shareholder approval. The five-year term runs from the 10th AGM to the 16th AGM.
Physicswallah Other Announcement
Physicswallah's IPO monitoring report flags a deviation from offer objects for the quarter ended September 30, 2026. The diverted funds were restored on October 30, 2026.
Gujarat Kidney and Super Speciality Other Announcement
Gujarat Kidney filed Brickwork's monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation from the IPO fund-utilisation objects.
PDS Other Announcement
PDS Limited submitted the CRISIL Ratings monitoring agency report for the quarter ended September 30, 2026. It confirms no deviation in the utilisation of its QIP proceeds.
Schaeffler India Other Announcement
Schaeffler India disclosed that CRISIL ESG Ratings assigned it an ESG Score of 67 on an unsolicited basis. The company did not engage or subscribe to the rating provider.